Analytical Data
-
基因名
VSTM1
- Application
-
别名
VSTM1；V-set and transmembrane domain-containing Protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6UX27-1
-
表达区间
1-135aa
-
氨基酸序列
MTAEFLSLLC LGLCLGYEDE KKNEKPPKPS LHAWPSSVVE AESNVTLKCQ AHSQNVTFVL RKVNDSGYK QEQSSAENEA EFPFTDLKPK DAGRYFCAYK TTASHEWSES SEHLQLVVTD KHDELEAPS MKTDTRT
-
分子量
15 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VSTM1, or V-set and transmembrane domain containing 1, is a protein that has garnered attention due to its potential roles in immune regulation and cellular signaling. Recent studies have indicated that VSTM1 may be involved in modulating immune cell interactions and responses, particularly in lymphocytes. Its expression patterns have been linked to various physiological and pathological conditions, including autoimmune diseases and cancers, suggesting that VSTM1 may play a critical role in maintaining immune homeostasis and tumorigenesis. The interest in VSTM1 has led to efforts to produce recombinant forms of the protein for functional studies, enabling researchers to explore its mechanisms of action at a molecular level. Investigating the structure and function of VSTM1, particularly its interactions with other immune system components, could provide valuable insights into its potential as a therapeutic target. By enhancing our understanding of VSTM1’s role, we may uncover novel strategies for treating immune-related disorders and improving immune responses to tumors.
